BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cappella M, Pradat PF, Querin G, Biferi MG. Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy. J Neuromuscul Dis 2021;8:25-38. [PMID: 33074186 DOI: 10.3233/JND-200531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Grassano M, Calvo A, Moglia C, Sbaiz L, Brunetti M, Barberis M, Casale F, Manera U, Vasta R, Canosa A, D'Alfonso S, Corrado L, Mazzini L, Dalgard C, Karra R, Chia R, Traynor B, Chiò A. Systematic evaluation of genetic mutations in ALS: a population-based study. J Neurol Neurosurg Psychiatry 2022:jnnp-2022-328931. [PMID: 35896380 DOI: 10.1136/jnnp-2022-328931] [Reference Citation Analysis]
2 Nova A, Baldrighi GN, Fazia T, Graziano F, Saddi V, Piras M, Beecham A, McCauley JL, Bernardinelli L. Heritability Estimation of Multiple Sclerosis Related Plasma Protein Levels in Sardinian Families with Immunochip Genotyping Data. Life (Basel) 2022;12:1101. [PMID: 35888189 DOI: 10.3390/life12071101] [Reference Citation Analysis]
3 Demarest TG, Biferi MG. Translation of gene therapy strategies for amyotrophic lateral sclerosis. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.07.001] [Reference Citation Analysis]
4 Richter MN, Fattahi F. Stem Cell-Based Models for Studying the Effects of Cancer and Cancer Therapies on the Peripheral Nervous System. Adv Biol (Weinh) 2022;:e2200009. [PMID: 35666079 DOI: 10.1002/adbi.202200009] [Reference Citation Analysis]
5 Shibuya K, Otani R, Suzuki Y, Kuwabara S, Kiernan MC. Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets. Pharmaceuticals 2022;15:433. [DOI: 10.3390/ph15040433] [Reference Citation Analysis]
6 Querin G, Grazia Biferi M, Pradat PF. Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials. J Neuromuscul Dis 2021. [PMID: 34864683 DOI: 10.3233/JND-210754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jankovic M, Novakovic I, Gamil Anwar Dawod P, Gamil Anwar Dawod A, Drinic A, Abdel Motaleb FI, Ducic S, Nikolic D. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Int J Mol Sci 2021;22:9832. [PMID: 34575995 DOI: 10.3390/ijms22189832] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Xu J, Zheng Y, Wang L, Liu Y, Wang X, Li Y, Chi G. miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases. Cell Mol Neurobiol 2021. [PMID: 33886036 DOI: 10.1007/s10571-021-01091-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Cappella M, Elouej S, Biferi MG. The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders. Front Cell Dev Biol 2021;9:662837. [PMID: 33937264 DOI: 10.3389/fcell.2021.662837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]